Both in Pharmaceuticals
Harrow vs MoonLake Immunotherapeutics
Over the past year HROW returned −26.5% and MLTX returned +2.0%; their daily moves had a correlation of 0.16.
HROW −26.5% MLTX +2.0%Growth of $1, one year, split-adjusted
| Metric | HROW | MLTX |
|---|---|---|
| Price | $26.04 | $10.80 |
| Market cap | $976.2M | $919.2M |
| Today | −9.43% | −6.57% |
| 1 month | −15.0% | +0.3% |
| 6 months | −33.3% | −37.2% |
| Year to date | −46.9% | −18.1% |
| 1 year | −26.3% | +6.6% |
| Revenue growth (YoY) | +10.9% | — |
| Gross margin | 71.3% | — |
| Net margin | −24.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.5× | — |
| Net cash | -$208.5M | $437.5M |
| Dividend yield | — | — |
| Volatility (60d) | 44.2% | 57.6% |
| Short % of float | 24.3% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).